GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Aroa Biosurgery Ltd (ASX:ARX) » Definitions » Total Liabilities

Aroa Biosurgery (ASX:ARX) Total Liabilities : A$14.79 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Aroa Biosurgery Total Liabilities?

Aroa Biosurgery's Total Liabilities for the quarter that ended in Mar. 2024 was A$14.79 Mil.

Aroa Biosurgery's quarterly Total Liabilities increased from Mar. 2023 (A$13.70 Mil) to Sep. 2023 (A$14.34 Mil) and increased from Sep. 2023 (A$14.34 Mil) to Mar. 2024 (A$14.79 Mil).

Aroa Biosurgery's annual Total Liabilities increased from Mar. 2022 (A$11.30 Mil) to Mar. 2023 (A$13.70 Mil) and increased from Mar. 2023 (A$13.70 Mil) to Mar. 2024 (A$14.79 Mil).


Aroa Biosurgery Total Liabilities Historical Data

The historical data trend for Aroa Biosurgery's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aroa Biosurgery Total Liabilities Chart

Aroa Biosurgery Annual Data
Trend Mar20 Mar21 Mar22 Mar23 Mar24
Total Liabilities
19.68 19.43 11.30 13.70 14.79

Aroa Biosurgery Semi-Annual Data
Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Total Liabilities Get a 7-Day Free Trial 11.30 12.40 13.70 14.34 14.79

Aroa Biosurgery Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Aroa Biosurgery's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8.728+(5.899+0.16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=14.79

Total Liabilities=Total Assets (A: Mar. 2024 )-Total Equity (A: Mar. 2024 )
=101.878-87.091
=14.79

Aroa Biosurgery's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8.728+(5.899+0.16
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+0)
=14.79

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=101.878-87.091
=14.79

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aroa Biosurgery Total Liabilities Related Terms

Thank you for viewing the detailed overview of Aroa Biosurgery's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Aroa Biosurgery (ASX:ARX) Business Description

Traded in Other Exchanges
N/A
Address
64 Richard Pearse Drive, Mangere, Airport Oaks, Auckland, NZL, 2022
Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.

Aroa Biosurgery (ASX:ARX) Headlines

No Headlines